Peritoneal dialysis first: rationale.
The use of peritoneal dialysis (PD) has become wide spread since the introduction of continuous ambulatory PD more than 25 years ago. Over this time, many advances have been made and PD is an alternative to hemodialysis (HD), with excellent comparable survival, lower cost, and improved quality of life. The percentage of prevalent PD patients in the United States is approximately 7%, which is significantly lower compared with the 15% PD prevalence from the mid-1980s. Despite comparable survival of HD and PD and improved PD technique survival over the last few years, the percentage of patients performing PD in the United States has declined. The increased numbers of in-center HD units, physician comfort with the modality, perceived superiority of HD, and reimbursement incentives have all contributed to the underutilization of PD. In addition to a higher transplantation rate among patients treated with PD in the United States, an important reason for the low PD prevalence is the transfer to HD. There are various reasons for the transfer (e.g., episodes of peritonitis, membrane failure, patient fatigue, etc.). This review discusses the various factors that contribute to PD underutilization and the rationale and strategies to implement "PD first" and how to maintain it. The PD first concept implies that when feasible, PD should be offered as the first dialysis modality. This concept of PD first and HD second must not be seen as a competition between therapies, but rather that they are complementary, keeping in mind the long-term goals for the patient.
Harry S. Truman VA Hospital, and Division of Nephrology, Department of Internal Medicine, University of Missouri, 1 Hospital Drive, CE 422, Columbia, MO 65212, USA. chaudharyk@health.missouri.edu
Kunal
K
Chaudhary
Harbaksh
H
Sangha
Ramesh
R
Khanna
D006801:Humans; D007674:Kidney Diseases / Q000401:mortality / Q000628:therapy*; D018579:Patient Selection; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000401:mortality / Q000706:statistics & numerical data*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000401:mortality / Q000706:statistics & numerical data*; D006435:Renal Dialysis / Q000706:statistics & numerical data; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome